Circulating miR-21 as a Potential Biomarker for the Diagnosis of Oral Cancer: A Systematic Review with Meta-Analysis
暂无分享,去创建一个
E. Coccia | V. Crincoli | L. Laino | L. Lo Muzio | G. Troiano | M. Alovisi | M. Dioguardi | Diego Sovereto | R. Aiuto | G. Caloro | D. Sovereto | G. A. Caloro
[1] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.
[2] H. Ishinaga,et al. A longitudinal study on circulating miR-21 as a therapeutic effect marker in head and neck squamous cell carcinoma. , 2019, Carcinogenesis.
[3] M. Saqib,et al. Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma , 2019, Pakistan journal of medical sciences.
[4] Yuehua Wu,et al. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer , 2019, Molecular therapy. Nucleic acids.
[5] N. Cirillo,et al. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis , 2018, Journal of dental research.
[6] S. A. Haider,et al. Genetic etiology of oral cancer. , 2017, Oral oncology.
[7] J. Hess,et al. Epidemiology and Molecular Biology of Head and Neck Cancer , 2017, Oncology Research and Treatment.
[8] Siyi Li,et al. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies , 2015, Tumor Biology.
[9] Xiaobing Fu,et al. The miRNA network: micro-regulator of cell signaling in cancer , 2014, Expert review of anticancer therapy.
[10] N. Yanaihara,et al. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma , 2014, BMC Cancer.
[11] Ling Gao,et al. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma , 2014, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[12] Mark Loeb,et al. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments , 2014, BMC Medical Research Methodology.
[13] Ying Peng,et al. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma , 2013, Cancer biology & therapy.
[14] Ming-Yu Yang,et al. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma , 2012, Tumor Biology.
[15] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[16] Susan Mallett,et al. QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.
[17] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[18] S. Shukla,et al. Exploring Chemical Modifications for siRNA Therapeutics: A Structural and Functional Outlook , 2010, ChemMedChem.
[19] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.
[20] C. Croce,et al. MicroRNAs in Cancer. , 2009, Annual review of medicine.
[21] S. Warnakulasuriya. Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.
[22] Danish Sayed,et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.
[23] Y. Hayashizaki,et al. Cancer research with non‐coding RNA , 2006, Cancer science.
[24] R. Shivdasani. MicroRNAs: regulators of gene expression and cell differentiation. , 2006, Blood.
[25] C. Croce. MicroRNAs in leukemia. , 2006, Clinical advances in hematology & oncology : H&O.
[26] A. Carvalho,et al. Natural history of untreated head and neck cancer. , 2000, European journal of cancer.
[27] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[28] A. Syrenicz,et al. Expression of selected angiogenesis-related small microRNAs in patients with abnormally increased secretion of glucocorticoids. , 2019, Endokrynologia Polska.
[29] N. Bahrami,et al. Evaluation of Circulating Serum 3 Types of microRNA as Biomarkers of Oral Squamous Cell Carcinoma; a Pilot Study. , 2019, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[30] S. Bala,et al. Emerging role of non-coding RNA in oral cancer. , 2018, Cellular signalling.
[31] D. Wiesenfeld,et al. Oral Cancer. , 2018, Australian dental journal.
[32] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[33] C. Croce,et al. MicroRNAs in cancer. , 2014, Annual review of pathology.
[34] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.